Federal Agricultural Mortgage Corporation (AGM) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the PharmaMAC second quarter 2025 earnings results conference call. At this time, all participant lines are in the listen-only mode. Following the presentation, we will conduct a question and answer session. And if at any time during this call you require immediate assistance, please press star zero for the operator. Also note that this call is being recorded on August 7, 2025. I would now like to turn the conference over to Jalpa Nazareth. Please go ahead. Good afternoon, and thank you for joining us for our second quarter 2025 earnings conference call. I'm Shelfa Nazareth, Senior Director of Investor Relations and Finance Strategy here at FarmerMac. As we begin, please note that the information provided during this call may contain forward-looking statements about the company's business, strategies, and prospects, which are based on management's current expectations and assumptions. These statements are not a guarantee of future performance and are subject to the risks and uncertainties that could cause our actual results to differ materially from those projected. Please refer to Pharmac's 2024 Annual Report and subsequent SEC filings for a full discussion of the company's risk factors. On today's call, we will also be discussing certain non-GAAP financial measures. Disclosures and reconciliations of these non-GAAP measures can be found in the most recent form 10Q and earnings release posted on PharmaMac's website, pharma.com, under the financial information portion of the investor section. Today, I'm joined by President and Chief Executive Officer Brad Nordholm, who will lead our discussion on second quarter 2025 results, and our Chief Business Officer, Zach Carpenter, who will discuss customer and market develo...